Pfizer sets sights on elimination of blinding disease trachoma by 2030 Ruchika Sharma26 Jun 2022 9:00 AM ISTThe ITI had initially hoped to eliminate the disease by 2020, but is now setting its sights on 2030.
Pfizer sued for patent infringement over Paxlovid Roshni Dhar25 Jun 2022 5:30 PM ISTPfizer Inc's blockbuster COVID-19 treatment Paxlovid violates an Enanta Pharmaceuticals Inc patent for its COVID drug still in development, according...
Health Bulletin 25/June/2022 Roshni Dhar25 Jun 2022 4:34 PM ISTHere are the top health stories for the day:Every harm, intimidation, obstruction or hindrance to healthcare professionals is violence: Kerala...
Pfizer sued for patent infringement over COVID-19 drug Paxlovid Ruchika Sharma24 Jun 2022 12:35 PM ISTEnanta requested an unspecified amount of money damages from Pfizer, including royalties.
Pfizer, Truveta join hands to accelerate safety insights in real time Ruchika Sharma22 Jun 2022 4:00 PM ISTBellevue: Truveta has announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable...
Pfizer to acquire 8.1 percent stake in Valneva Ruchika Sharma20 Jun 2022 10:30 AM ISTValneva is planning to use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program.
Pfizer halts COVID drug Paxlovid trial for standard-risk population Ruchika Sharma16 Jun 2022 2:47 PM ISTThe new data, however, showed a 51% relative risk reduction in standard-risk groups, which the company said was not statistically significant.
Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 1:45 PM ISTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
Pfizer Myfembree sNDA accepted by USFDA for review Ruchika Sharma6 Jun 2022 2:15 PM ISTMYFEMBREE was approved in the U.S. in 2021 for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women with...
Pfizer appoints Annaliesa Anderson as Senior Vice President Ruchika Sharma4 Jun 2022 4:52 PM ISTNew York: Pfizer Inc. has announced that Annaliesa Anderson, Ph.D., has been appointed Senior Vice President and Head of the Company's Vaccine...
Study says Pfizer COVID drug Paxlovid reduces COVID risk in seniors regardless of vaccine status Ruchika Sharma3 Jun 2022 1:17 PM ISTPfizer's clinical trial tested Paxlovid in unvaccinated people who had risk factors for serious disease and found that the two-drug treatment cut the...
Pfizer-BioNTech seeks USFDA authorisation for COVID vaccine for kids under 5 years Ruchika Sharma3 Jun 2022 11:30 AM ISTNo COVID-19 shot is yet approved for children in that age group in most parts of the world.
